In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction
    Burzotta, F
    Di Castelnuovo, A
    Amore, C
    D'Orazio, A
    Di Bitondo, R
    Donati, MB
    Iacoviello, L
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (02) : 354 - 358
  • [22] Plasma PAI-1 levels in obese children -: Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype
    Estellés, A
    Dalmou, J
    Falcó, C
    Berbel, O
    Castelló, R
    España, F
    Aznar, J
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (02) : 647 - 652
  • [23] Plasminogen activator inhibitor-1 (PAI-1) content in platelets from healthy individuals genotyped for the 4G/5G polymorphism in the PAI-1 gene
    Nordenhem, A
    Wiman, B
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1997, 57 (05): : 453 - 461
  • [24] PAI-1 4G/5G polymorphisms and PAI-1 levels during the acute phase of ischemic stroke.
    De Lucia, D
    Maisto, G
    De Francesco, F
    Del Giudice, V
    Quarantiello, M
    Papa, ML
    Margaglione, M
    Perrotta, S
    del Giudice, EM
    Nobili, B
    BLOOD, 2000, 96 (11) : 92B - 92B
  • [25] Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels
    Zietz, B
    Buechler, C
    Drobnik, W
    Herfarth, H
    Schölmerich, J
    Schäffler, MD
    ENDOCRINE RESEARCH, 2004, 30 (03) : 443 - 453
  • [26] The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: Relationship to plasma PAI-1 level in venous thromboembolism
    Stegnar, M
    Uhrin, P
    Peternel, P
    Mavri, A
    Salobir-Pajnic, B
    Stare, J
    Binder, BR
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (05) : 975 - 979
  • [27] Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
    L Lorente
    M Martín
    L Labarta
    C Díaz
    J Solé-Violán
    J Blanquer
    J Borreguero
    Y Barrios
    Critical Care, 13 (Suppl 1):
  • [28] Distribution of PAI-1 promoter 4G/5G polymorphism in Chinese and expression of luciferase reporter vector containing PAI-1 promoter.
    Ding, ZR
    Pan, JQ
    Li, XR
    BLOOD, 2000, 96 (11) : 72B - 72B
  • [29] 4G/5G polymorphism modulates PAI-1 circulating levels in obese women
    Fernandes, Karla S.
    Sandrim, Valeria C.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2012, 364 (1-2) : 299 - 301
  • [30] PAI-1 4G/5G polymorphism and antiphospholipid antibodies (APA) in pregnancy complications
    Bellia, M.
    Apergis, G.
    Gafou, A.
    Nomikou, E.
    Pevlou, E.
    Zafiri, C.
    Andrioti, E.
    BLOOD REVIEWS, 2007, 21 : S104 - S105